Healthcare -
Biotechnology - NASDAQ - US
$ 34.055
1.23 %
$ 14.8 B
Market Cap
17.83
P/E
RPRX - OPERATING EXPENSES
Operating Expenses RPRX - Royalty Pharma plc
971 M
LAST VALUE
-14.05%
2 YEAR CAGR
26.19%
5 YEAR CAGR
0.00%
10 YEAR CAGR